PANGIA ROBERT W 4
4 · BIOGEN INC. · Filed Mar 19, 2019
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
PANGIA ROBERT W
Director
Transactions
- Sale
Common Stock
2019-03-18$328.55/sh−6,114$2,008,755→ 18,587 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-03-18−6,114→ 0 totalExercise: $53.43From: 2010-06-03Exp: 2019-06-02→ Common Stock (6,114 underlying) - Exercise/Conversion
Common Stock
2019-03-18$52.22/sh+6,114$319,273→ 24,701 total
Footnotes (3)
- [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]This option was previously reported as covering 5,975 shares at an exercise price of $53.43 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017.
- [F3]Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d).